Use of Testosterone in Postmenopausal Women.
Female sexual dysfunction
Postmenopausal women
Testosterone therapy
Journal
Endocrinology and metabolism clinics of North America
ISSN: 1558-4410
Titre abrégé: Endocrinol Metab Clin North Am
Pays: United States
ID NLM: 8800104
Informations de publication
Date de publication:
03 2021
03 2021
Historique:
entrez:
1
2
2021
pubmed:
2
2
2021
medline:
26
10
2021
Statut:
ppublish
Résumé
The role of testosterone in women and its potential as a therapeutic agent continue to attract controversy. The clinical trials of testosterone therapy for women primarily have focused on treatment of female sexual dysfunction, with the largest placebo-controlled studies being of transdermal testosterone in postmenopausal women. Based on the cumulative data from these studies, loss of sexual desire with associated personal distress currently is the only agreed-on indication for judicious testosterone supplementation for postmenopausal women. This article reviews the physiology of testosterone in women, summarizes the findings from observational studies and clinical trials, and considers indications for testosterone use.
Identifiants
pubmed: 33518180
pii: S0889-8529(20)30088-8
doi: 10.1016/j.ecl.2020.11.002
pii:
doi:
Substances chimiques
Androgens
0
Testosterone
3XMK78S47O
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
113-124Informations de copyright
Copyright © 2020 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Disclosures Dr S.R. Davis reports having received honoraria from BioFemme, Besins Healthcare, and Pfizer Australia. She has also been a consultant to Mayne Pharmaceuticals, Lawley Pharmaceuticals, Roche Pharmaceuticals, Que Oncology, Abbott Pharmaceuticals, and Astellas Pharmaceuticals.